Corbion Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

CorbionDie Umsatzerlöse des Unternehmens werden voraussichtlich um 0.2% pro Jahr zurückgehen, während die jährlichen Gewinne voraussichtlich um 8.7% pro Jahr wachsen werden. Der Gewinn pro Aktie wird voraussichtlich um 18.6% pro Jahr wachsen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.3% betragen.

Wichtige Informationen

8.7%

Wachstumsrate der Gewinne

18.6%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	21.8%
Wachstumsrate der Einnahmen	-0.2%
Zukünftige Eigenkapitalrendite	11.3%
Analystenabdeckung	Low
Zuletzt aktualisiert	30 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Nov 18

An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued

Oct 31

Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt

Sep 26

The Price Is Right For Corbion N.V. (AMS:CRBN)

Jul 18

Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jun 20

Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

May 08

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Jun 04

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Apr 21

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Mar 10

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Feb 22

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Jan 26

Is Corbion (AMS:CRBN) Using Too Much Debt?

Dec 20

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Nov 24

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Nov 09

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Oct 08

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Sep 19

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Aug 23

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Jul 21

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Jul 06

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

May 20

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

May 17

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Apr 28

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Apr 07

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Mar 26

Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56

Feb 27

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Feb 27

At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?

Feb 13

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Jan 26

Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock

Dec 22

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Dec 10

Is Corbion N.V. (AMS:CRBN) Worth €40.3 Based On Its Intrinsic Value?

Oct 25

We Think Corbion (AMS:CRBN) Is Taking Some Risk With Its Debt

Sep 21

Corbion (AMS:CRBN) Could Be Struggling To Allocate Capital

Sep 01

I Ran A Stock Scan For Earnings Growth And Corbion (AMS:CRBN) Passed With Ease

Aug 17

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

May 02

Gewinn- und Umsatzwachstumsprognosen

ENXTAM:CRBN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,396	103	55	169	5
12/31/2025	1,334	86	68	177	5
12/31/2024	1,298	90	62	135	5
6/30/2024	1,439	80	66	171	N/A
3/31/2024	1,442	77	41	168	N/A
12/31/2023	1,444	73	16	165	N/A
9/30/2023	1,380	57	-61	121	N/A
6/30/2023	1,412	54	-139	77	N/A
3/31/2023	1,435	72	-168	58	N/A
12/31/2022	1,458	90	-197	39	N/A
9/30/2022	1,350	76	-190	32	N/A
6/30/2022	1,243	63	-184	25	N/A
3/31/2022	1,157	70	-155	24	N/A
12/31/2021	1,071	78	-126	22	N/A
9/30/2021	1,040	97	-65	59	N/A
6/30/2021	1,010	116	-4	97	N/A
3/31/2021	998	95	8	103	N/A
12/31/2020	987	73	20	109	N/A
9/30/2020	992	49	20	108	N/A
6/30/2020	997	24	19	107	N/A
3/31/2020	987	25	29	111	N/A
12/31/2019	976	26	38	114	N/A
9/30/2019	953	37	39	109	N/A
6/30/2019	930	48	40	105	N/A
3/31/2019	914	51	40	102	N/A
12/31/2018	897	54	39	100	N/A
9/30/2018	883	61	56	109	N/A
6/30/2018	869	69	74	119	N/A
3/31/2018	880	77	N/A	118	N/A
12/31/2017	892	85	N/A	118	N/A
9/30/2017	905	87	N/A	109	N/A
6/30/2017	918	89	N/A	101	N/A
3/31/2017	914	95	N/A	112	N/A
12/31/2016	911	102	N/A	123	N/A
9/30/2016	917	103	N/A	124	N/A
6/30/2016	922	104	N/A	126	N/A
3/31/2016	920	91	N/A	118	N/A
12/31/2015	918	78	N/A	110	N/A
9/30/2015	885	45	N/A	93	N/A
6/30/2015	851	13	N/A	75	N/A
3/31/2015	811	-4	N/A	71	N/A
12/31/2014	770	-21	N/A	67	N/A
9/30/2014	757	-15	N/A	51	N/A
6/30/2014	744	-9	N/A	34	N/A
3/31/2014	744	-3	N/A	22	N/A
12/31/2013	744	2	N/A	10	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CRBNDas prognostizierte Gewinnwachstum (8.7% pro Jahr) liegt über der Sparquote (1.2%).

Ertrag vs. Markt: CRBNDie Erträge des Unternehmens (8.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Dutch (16.3% pro Jahr).

Hohe Wachstumserträge: CRBNDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CRBNDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-0.2% pro Jahr).

Hohe Wachstumseinnahmen: CRBNDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-0.2% pro Jahr).

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CRBNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.3%).

Corbion Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 18%

Price target decreased by 9.5% to €22.10

Price target decreased by 9.7% to €26.33

Consensus EPS estimates fall by 10%, revenue upgraded

Consensus EPS estimates fall by 26%, revenue upgraded

Price target decreased by 14% to €31.63

Recent updates

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued

Now 21% undervalued

New major risk - Revenue and earnings growth

Corbion N.V. to Report Q2, 2025 Results on Jul 31, 2025

Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt

First half 2024 earnings released: EPS: €0.39 (vs €0.26 in 1H 2023)

The Price Is Right For Corbion N.V. (AMS:CRBN)

Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate

Now 20% undervalued

Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely

Final dividend of €0.61 announced

Now 23% overvalued

Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?

Corbion Appoints Masha Vis-Mertens as Chief Human Resources Officer and Member of the Executive Committee as of 1 May 2024

Kingswood Capital Management, L.P. completed the acquisition of Emulsifiers business from Corbion N.V.

Corbion Announces Preliminary Results of New Study from Millennial Salmon Project

Dividend of €0.61 announced

Full year 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 18%

Price target decreased by 9.5% to €22.10

Investor sentiment improves as stock rises 22%

Kingswood Capital Management, L.P. singed a binding agreement to acquire Emulsifiers business from Corbion N.V for $362 million.

Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion N.V. to Report Fiscal Year 2023 Results on Mar 01, 2024

Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)

Price target decreased by 9.7% to €26.33

Consensus EPS estimates fall by 10%, revenue upgraded

Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet

First half 2023 earnings released: EPS: €0.48 (vs €0.88 in 1H 2022)

Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)

When Should You Buy Corbion N.V. (AMS:CRBN)?

Consensus EPS estimates fall by 26%, revenue upgraded

Price target decreased by 14% to €31.63

New minor risk - Dividend sustainability

Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate

Corbion N.V. Approves Dividend for the Year 2022, Payable on 30 May 2023

Upcoming dividend of €0.56 per share at 1.9% yield

Insider recently bought €142k worth of stock

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Consensus EPS estimates fall by 16%, revenue upgraded

Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business

Price target increased to €36.28

Is Corbion (AMS:CRBN) Using Too Much Debt?

Corbion N.V. Appoints Jennifer Lindsey as Chief Marketing and Digital Officer

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Price target decreased to €33.03

Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?

Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden

Now 20% undervalued after recent price drop

A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

First half 2022 earnings released

Investor sentiment improved over the past week

Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?

Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Corbion N.V. Announces Executive Changes

Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)

Upcoming dividend of €0.56 per share

Consensus forecasts updated

Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56

Price target decreased to €40.82

Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56

Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business